000 01177 a2200313 4500
005 20250513191457.0
264 0 _c19990930
008 199909s 0 0 eng d
022 _a0190-9622
024 7 _a10.1016/s0190-9622(99)70362-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLebwohl, M
245 0 0 _aAcitretin in combination with UVB or PUVA.
_h[electronic resource]
260 _bJournal of the American Academy of Dermatology
_cSep 1999
300 _aS22-4 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAcitretin
_xtherapeutic use
650 0 4 _aCombined Modality Therapy
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDose-Response Relationship, Radiation
650 0 4 _aHumans
650 0 4 _aKeratolytic Agents
_xtherapeutic use
650 0 4 _aPUVA Therapy
650 0 4 _aPsoriasis
_xdrug therapy
650 0 4 _aTreatment Outcome
650 0 4 _aUltraviolet Therapy
773 0 _tJournal of the American Academy of Dermatology
_gvol. 41
_gno. 3 Pt 2
_gp. S22-4
856 4 0 _uhttps://doi.org/10.1016/s0190-9622(99)70362-2
_zAvailable from publisher's website
999 _c10416751
_d10416751